Skip to content
Open access

Surveillance Mammography and Second Primary Breast Cancer Diagnosis Among Older Women With a History of Breast Cancer.

Nov 2026 · JAMA Internal Medicine · 0 citations · 28 references
Medicine

TL;DR

It is suggested that among older survivors of breast cancer, continued surveillance mammography was not associated with a reduced risk of advanced second primary breast cancer, and surveillance decisions should be individualized given the potential burdens of continued surveillance.

Abstract

Importance Although surveillance mammography is commonly performed among older women, whether this practice improves clinical outcomes in this population is uncertain. Objective To evaluate the association between surveillance mammography and second primary breast cancer stage at diagnosis among older women with a history of breast cancer. Design, Setting, and Participants This retrospective longitudinal cohort study used Surveillance, Epidemiology, and End Results Program-Medicare data. Women with nonmetastatic breast cancer that was diagnosed from 2004 to 2008 at 67 years or older who had a surveillance mammogram at approximately 5 years after diagnosis were included. Analyses used cause-specific hazard models with inverse probability of treatment weighting to estimate the risk of stage-specific second primary breast cancer among women who continued surveillance mammography and those who did not. Analyses were stratified by hormone receptor (HR) status of the initial breast cancer. Follow-up continued until second breast cancer diagnosis, death, or end of the study (December 2021). Analyses were performed between November 2025 and August 2026. Exposure Continued surveillance mammography more than 5 years after initial diagnosis. Main Outcomes and Measures Stage-specific cumulative incidence of a second primary breast cancer, categorized as in situ, localized, or advanced (regional or distant). Results Among 9888 women (mean [SD] age, 81.1 [5.5] years; 387 Hispanic [3.9%], 514 non-Hispanic Black [5.1%], and 8514 White individuals [86.1%]), 8055 (81.4%) had in situ or localized disease and 7621 (76.9%) had HR-positive tumors at initial diagnosis. Overall, 7940 women (80.3%) continued surveillance at cohort entry. Advanced second primary breast cancer was rare, and incidence did not differ among those who continued surveillance and those who did not (cumulative incidence, 1.65% vs 2.15%; hazard ratio, 0.76; 95% CI, 0.46-1.26). Results were similar in subgroups of women with initial HR-positive and HR-negative breast cancer. Conclusions and Relevance The results of this cohort study suggest that among older survivors of breast cancer, continued surveillance mammography was not associated with a reduced risk of advanced second primary breast cancer. The absolute risk of advanced cancer was low, and surveillance decisions should be individualized given the potential burdens of continued surveillance.

Read PDF

Similar papers

Oct 2026

Abstract B161: Longitudinal surveillance mammography phenotypes among older breast cancer survivors

Older age, African American race, Hispanic ethnicity, and neighborhood deprivation were associated with limited surveillance adherence, highlighting populations that may benefit from targeted interventions to improve long-term surveillance mammography adherence.

Lu-Chang Cui, Swarnavo Sarkar, Eunji Choi et al. · 0 citations
Open access Oct 2026

Temporal trends and correlates of stage at diagnosis, receipt of treatment, and survival among men newly diagnosed with breast cancer in the United States.

212 Background: Male breast cancer is rare, accounting for approximately 1% of all breast cancer diagnoses and 0.5% of all cancer diagnoses among men in the US. Despite its commonly delayed diagnosis and treatment and poor prognosis, existing research on male breast cancer has been limited by small sample sizes...

Vincent Nguyen, Xue-Song Han, F. Chino et al. · 0 citations
Sep 2026

Detection Patterns of Breast Cancer Recurrence and Contralateral New Primaries in a Large Integrated Health System.

BACKGROUND Optimizing surveillance for the growing population of breast cancer survivors remains a challenge. Although screening guidelines for initial breast cancer are well established, current surveillance guidelines recommending routine provider examinations rely heavily on expert consensus rather than real-world d...

A. Duffens, Cecile A. Laurent, I. Ergas et al. · 0 citations
Review Open access 2026

Effectiveness of mammographic screening for reducing breast cancer mortality in women aged 40 to 49 years

Mammographic screening in women aged 40–49 years was associated with a significant decrease in breast cancer mortality, and the findings suggest potential benefits and support consideration of screening expansion to this population.

Nícolas Marques Barros, Igor Diniz Alves, Walter Johnatha dos Santos Pereira et al. · 0 citations
Open access Oct 2026

Baseline prevalence of lung cancer screening and associated factors among women in breast cancer screening clinics prior to the Pink & Pearl program: A retrospective analysis of electronic health records

The need for strategies to improve smoking history documentation and promote tobacco cessation efforts in cancer screening programs is highlighted and the Pink & Pearl program, a co-located breast and lung cancer screening initiative at these sites, will be evaluated.

B. Odeny, Sri Gopalsamy Ramaswamy, Benjamin Bowe et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.